|

Foralumab TZLS-401 100 µg Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 2

Top Sponsors

  • Tiziana Life Sciences LTD1
  • Brigham and Women's Hospital1

Indications

  • Non-Active Secondary Progressive Multiple Sclerosis1
  • Mild Cognitive Impairment Due to Alzheimer's Disease1
  • Alzheimers Disease1
  • Alzheimer's Disease1
  • Dementia1

Boston, Massachusetts2 trials

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

Center for Alzheimer Research and Treatment, Brigham and Women's Hospital

Phase 2
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

Brigham and Women's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.